Target intelligence / Profile preview

Beta-glucosidase (Bacillus) (BGL)

Target
BGL
Molecular classification
Enzyme, Hydrolase, Glycoside hydrolase family 1 (GH1), Glycoside hydrolase family 3 (GH3), Glycoside hydrolase family 4 (GH4)
01

Overview

Bacillus beta-glucosidase is a glycoside hydrolase enzyme produced by various species of the Bacillus genus, most notably Bacillus subtilis and Bacillus polymyxa. It plays a critical role in the final step of cellulose degradation by hydrolyzing cellobiose and other short-chain cello-oligosaccharides into glucose. In the context of human health, bacterial beta-glucosidases within the gastrointestinal tract are involved in the metabolism of dietary glycosides and xenobiotics, often converting them into more bioactive or potentially toxic aglycones. While primarily utilized in industrial biotechnology for biofuel production and food processing, these enzymes are also of interest in pharmacology as targets for inhibitors like 1-deoxynojirimycin to modulate carbohydrate metabolism or prevent the activation of certain prodrugs. Furthermore, they serve as important models for studying glycoside hydrolase mechanisms and are being explored for potential roles in enzyme replacement therapies or as components of probiotic formulations. Their activity is essential for the survival of cellulolytic bacteria and significantly influences the bioavailability of glycosylated compounds in the gut.

Other names
GentiobiaseCellobiaseAmygdalaseBeta-D-glucoside glucohydrolaseBglBglABglB
02

Mechanism of action

Hydrolysis of terminal, non-reducing beta-D-glucosyl residues with the release of beta-D-glucose.

03

Biological functions

Cellulose degradationCarbohydrate metabolismHydrolysis of beta-1,4-glycosidic bondsXenobiotic metabolismRelease of glucose from oligosaccharides
04

Disease associations

Other (Gut microbiome-mediated drug metabolism)Other (Biofuel production and industrial biotechnology)
05

Safety considerations

Immunogenicity (if used as a therapeutic protein)Potential for drug-drug interactions via gut microbiota metabolismAlteration of normal gut flora carbohydrate processing
06

Interacting drugs

1-Deoxynojirimycin

4 more in the full profile.

Beyond the preview

Go deeper on Beta-glucosidase (Bacillus) (BGL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta-glucosidase (Bacillus) (BGL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call